{
  "id": "c15bc9b58fa477be4c5a56505d2b31e6da833117",
  "title": "Trump’s MFN drug pricing impact still unclear in Denmark and Sweden [Advocacy Lab]",
  "summary_full": "Denmark and Sweden are assessing how Trump’s 'Most Favoured Nation' push is affecting medicine access, now and long-term, despite safeguards in their value-based models",
  "summary_public": "Denmark and Sweden are assessing how Trump’s 'Most Favoured Nation' push is affecting medicine access, now and long-term, despite safeguards in their value-based models",
  "url": "https://www.euractiv.com/news/trumps-mfn-drug-pricing-impact-still-unclear-in-denmark-and-sweden/",
  "published_at": "2026-02-23T02:18:30+00:00",
  "source": "Euractiv",
  "language": "en",
  "countries_detected": [
    "DK",
    "SE"
  ],
  "countries_scored": [
    "DK",
    "SE"
  ],
  "sentiment_by_country": {
    "DK": {
      "label": "neutral",
      "confidence": 0.3,
      "evidence": "Denmark and Sweden are assessing how Trump’s 'Most Favoured Nation' push"
    },
    "SE": {
      "label": "neutral",
      "confidence": 0.3,
      "evidence": "Denmark and Sweden are assessing how Trump’s 'Most Favoured Nation' push"
    }
  },
  "llm_version": "v3-eu",
  "llm_perspective": "EU",
  "llm_attempted_at": "2026-02-23T10:11:37+00:00",
  "processed_at": "2026-02-23T10:11:37+00:00"
}